Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture Thereof - EP2461802

The patent EP2461802 was granted to Sofar on Aug 3, 2022. The application was originally filed on Jul 21, 2010 under application number EP10752187A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2461802

SOFAR
Application Number
EP10752187A
Filing Date
Jul 21, 2010
Status
Patent Maintained As Amended
Jul 1, 2022
Grant Date
Aug 3, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TILLOTTS PHARMAFeb 28, 2019BECK GREENER -

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO0168058
INTERNATIONAL-SEARCH-REPORTWO2006130703
INTERNATIONAL-SEARCH-REPORTWO2009114773
OPPOSITIONEP0277741
OPPOSITIONEP0629398
OPPOSITIONUS2002192282
OPPOSITIONUS2003180352
OPPOSITIONWO0166094
OPPOSITIONWO2006130703
OPPOSITIONWO9636319
OPPOSITIONWO9822096

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents